Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis

Metformin-Induced Vitamin B12 Deficiency Presenting as a Peripheral Neuropathy

(2011) David S.H. Bell   SOUTHERN MEDICAL JOURNAL

Androgens and polycystic ovary syndrome

(2011) Vicki Nisenblat et al.   Current Opinion in Endocrinology Diabetes and Obesity

Risk of Fractures with Glitazones

(2009) Michael Bodmer et al.   DRUG SAFETY

The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

(2009) Niki Katsiki et al.   DRUGS

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

(2009) Evanthia Diamanti-Kandarakis et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

(2009) Robert F. Kushner et al.   Obesity

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome

(2008) L. W. Cho et al.   CLINICAL ENDOCRINOLOGY

Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome

(2008) Mojca Jensterle et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial

(2008) Vanita R. Aroda et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metformin versus Insulin for the Treatment of Gestational Diabetes

(2008) Janet A. Rowan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal

(2008) Andrea Dunaif   Nature clinical practice. Endocrinology & metabolism